Mitral Valve Disease: Understanding Your Surgical Options When Repair and Replacement Are Both on the Table

Why the Choice Between Mitral Valve Repair vs Replacement Matters More Than You Think

If you or someone you love has been told they need surgery for mitral valve disease, you are facing one of the most consequential decisions in cardiac surgery. The mitral valve sits between the left atrium and left ventricle — the two chambers responsible for pumping oxygenated blood to your entire body. When it fails, the heart works harder to compensate, and over time, that strain can lead to heart failure, atrial fibrillation, and a shortened life.

Here is what I want you to understand upfront: not all mitral valve operations are equal, and not all surgeons approach the mitral valve the same way. The difference between repair and replacement can affect your long-term survival, your need for blood thinners, your risk of reoperation, and your quality of life for decades. This is not a decision to make passively.

In my practice, I have seen patients referred for mitral valve replacement who were excellent candidates for repair — and vice versa. The right answer depends on your specific valve anatomy, the cause of your disease, and the expertise of the surgeon performing the operation. Let me walk you through what you need to know.

Understanding Mitral Regurgitation: The Most Common Reason for Mitral Valve Surgery

Mitral regurgitation — a leaking mitral valve — is the most common valve disorder requiring surgery. According to the American Heart Association, moderate-to-severe mitral regurgitation affects more than 4 million people in the United States. There are two broad categories, and this distinction is critical to your treatment plan:

• Primary (degenerative) mitral regurgitation: The valve itself is structurally abnormal. The most common cause is mitral valve prolapse, where one or both valve leaflets are floppy, elongated, or have ruptured chordae (the tiny cords that tether the valve). This is often called degenerative mitral valve disease, and it is the scenario where repair is almost always preferred when performed by an experienced surgeon.
• Secondary (functional) mitral regurgitation: The valve leaflets themselves are structurally normal, but the heart has dilated — usually from coronary artery disease or cardiomyopathy — pulling the valve apart so it no longer closes properly. Treatment here is more nuanced, and the role of surgery versus medical therapy versus catheter-based options is an active area of debate.

Knowing which type of mitral regurgitation you have is the single most important factor in determining your treatment path. If your cardiologist or surgeon has not clearly explained this distinction to you, that is a red flag worth addressing before you consent to any procedure.

When Does Mitral Regurgitation Require Surgery?

The ACC/AHA 2020 guidelines for valvular heart disease recommend surgery for severe primary mitral regurgitation when:

• You have symptoms — shortness of breath, fatigue, reduced exercise tolerance, or heart failure
• You are asymptomatic but your heart is starting to show strain: a left ventricular ejection fraction (LVEF) dropping to 60% or below, or a left ventricular end-systolic dimension reaching 40mm or greater
• You develop new-onset atrial fibrillation or pulmonary hypertension

Importantly, the guidelines also state that early surgery is reasonable for asymptomatic patients with severe degenerative mitral regurgitation when the likelihood of a successful and durable repair is greater than 95% — but only at an experienced center with a high repair rate. This is where the surgeon and institution you choose become as important as the decision to operate.

Mitral Valve Repair vs Replacement: What the Evidence Actually Shows

Let me be direct about what decades of data tell us:

For degenerative mitral valve disease, repair is superior to replacement in virtually every measurable outcome. Studies consistently demonstrate that patients who undergo successful mitral valve repair have:

• Better long-term survival — multiple large studies, including data from the Society of Thoracic Surgeons (STS) database, show a survival advantage for repair over replacement that persists for 15 to 20 years
• Lower operative mortality — approximately 1% or less for repair at experienced centers, compared to 3-5% for replacement
• Preservation of left ventricular function — repair keeps the native valve apparatus intact, which is critical for the heart's pumping mechanics
• No need for lifelong anticoagulation — mechanical replacement valves require warfarin for life, with all its associated bleeding risks
• Lower risk of endocarditis (valve infection) compared to prosthetic valves
• Freedom from structural valve deterioration — a repaired native valve can last a lifetime, whereas bioprosthetic replacement valves typically degenerate over 10-20 years

These are not marginal differences. For a 55-year-old patient with degenerative mitral regurgitation, the choice between repair and replacement can meaningfully influence whether they are alive, active, and off blood thinners at age 75.

When Is Replacement the Better Option?

Replacement is not always the wrong answer. There are situations where it is the appropriate — and sometimes the safer — choice:

• Heavily calcified or destroyed valves where the leaflet tissue is too damaged to reconstruct reliably
• Rheumatic mitral valve disease, which is common globally and often involves thickened, retracted, fused leaflets that are not amenable to durable repair
• Failed prior repair requiring reoperation, where the anatomy has been altered
• Secondary mitral regurgitation with severely dilated ventricles, where repair alone has shown high recurrence rates in some studies
• Active endocarditis with extensive tissue destruction

The key is that the decision should be made based on your specific anatomy and pathology — not on the surgeon's comfort level. And this is where I want to be candid: if your surgeon tells you that your degenerative mitral valve cannot be repaired, and you have not been evaluated at a reference center with a repair rate above 95%, you owe it to yourself to seek another opinion.

Mitral Valve Surgery Options Beyond Open Surgery: What About MitraClip and Minimally Invasive Approaches?

Patients frequently ask me about catheter-based options, specifically the MitraClip (now called the Abbott TEER system). Here is the honest picture:

Transcatheter edge-to-edge repair (TEER) is a less invasive procedure performed through a vein in the groin, where a clip is placed on the mitral valve leaflets to reduce regurgitation. It does not require open-heart surgery or cardiopulmonary bypass. The COAPT trial demonstrated significant benefit for TEER in patients with secondary mitral regurgitation who remained symptomatic despite optimal medical therapy.

However, TEER is not a substitute for surgical repair in patients who are reasonable surgical candidates with degenerative mitral disease. The degree of regurgitation reduction is less complete, durability data are still maturing, and patients with complex degenerative anatomy are generally better served by a skilled surgeon who can reconstruct the valve definitively.

TEER has an important role for:

• Patients with secondary mitral regurgitation who are not surgical candidates
• Elderly or high-risk patients where open surgery carries prohibitive risk
• Patients who have been evaluated by a heart team and deemed better suited for a less invasive approach

Similarly, minimally invasive mitral valve surgery — performed through small incisions using robotic assistance or direct vision — offers many patients the benefits of surgical repair with less trauma, shorter hospital stays, and faster recovery. At high-volume centers, outcomes are comparable to traditional sternotomy. But the critical variable is not the size of the incision — it is the quality and durability of the repair.

If you want to understand how surgical risk is estimated for your specific situation, our free cardiac surgery risk calculator can give you a starting point based on validated scoring models.

How to Make the Right Mitral Regurgitation Treatment Decision

After years of operating on mitral valves and reviewing cases for patients seeking clarity, here is my practical advice:

1. Confirm your diagnosis. Make sure you have had a high-quality transthoracic echocardiogram — and ideally a transesophageal echocardiogram (TEE) — that clearly grades the severity and mechanism of your mitral regurgitation. The mechanism matters as much as the severity.

2. Ask your surgeon directly: what is your personal mitral valve repair rate for degenerative disease? The STS database shows the national average repair rate for degenerative mitral regurgitation is around 65-70%. At reference centers, it exceeds 95%. This gap is enormous and directly affects your outcome. You have every right to ask this question, and any surgeon worth operating on you will answer it without hesitation.

3. Understand what operation is being proposed and why. If replacement is recommended, ask specifically why repair is not feasible. If the answer is vague or does not reference your specific valve anatomy, consider seeking another perspective.

4. Do not let urgency replace diligence. Unless you are in cardiogenic shock or acute decompensation, most mitral valve surgery is planned weeks in advance. You have time to get a second opinion. In fact, getting a second opinion from an independent cardiac surgeon is one of the highest-value steps you can take before committing to an operation that will affect the rest of your life.

5. Consider the full picture. If you also have atrial fibrillation, coronary artery disease, or tricuspid regurgitation, these conditions may need to be addressed at the same operation. A comprehensive surgical plan matters. A second opinion can identify whether concomitant procedures are being appropriately considered — or inappropriately omitted.

The Volume-Outcome Relationship Is Real

This is not theoretical. Published data from multiple national registries confirm that hospitals and surgeons performing higher volumes of mitral valve repair achieve better outcomes — higher repair rates, lower mortality, fewer complications, and more durable results. The ACC/AHA guidelines explicitly recommend that patients with degenerative mitral regurgitation be referred to experienced centers when surgical intervention is planned.

If you are being told you need mitral valve surgery at a center that performs fewer than 25 mitral repairs per year, you should strongly consider whether that is where you want this operation performed.

Getting Clarity Before Your Mitral Valve Operation

The decision between mitral valve repair and replacement is not just a technical surgical question — it is a decision that shapes your long-term health, your medication burden, and your risk of future cardiac events. You deserve to understand your options fully, and you deserve confidence that the plan being recommended is the best one for your anatomy and your life.

If you are facing mitral valve surgery and want to be certain that the recommended approach — repair, replacement, minimally invasive, or catheter-based — is truly the right one for you, a WhiteGloveMD second opinion can help. Our board-certified cardiac surgeons review your imaging, your records, and your clinical picture to give you an independent, expert assessment. No guesswork. No generic advice. Just a clear, evidence-based recommendation tailored to you. Start your review today.